(Q43107580)

14 November 2017

0 references

Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis (English)

1 reference

14 November 2017

Fumio Omata

1

1 reference

14 November 2017

Gautam Deshpande

2

1 reference

14 November 2017

Yasuharu Tokuda

3

1 reference

14 November 2017

Osamu Takahashi

4

1 reference

14 November 2017

Sachiko Ohde

5

1 reference

14 November 2017

David L Carr-Locke

6

1 reference

14 November 2017

Joshua L Jacobs

7

1 reference

14 November 2017

Tetsuya Mine

8

1 reference

14 November 2017

Tsuguya Fukui

9

1 reference

14 November 2017

7 April 2010

1 reference

Journal of Gastroenterology

14 November 2017

1 reference

14 November 2017

45

1 reference

14 November 2017

8

1 reference

14 November 2017

885-895

1 reference

Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis

14 November 2017

1 reference

12 December 2020

Use of corticosteroids in the prevention of post-ERCP pancreatitis

1 reference

12 December 2020

Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial

1 reference

12 December 2020

Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate

1 reference

12 December 2020

Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials

1 reference

12 December 2020

Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group

1 reference

12 December 2020

Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy

1 reference

12 December 2020

The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial

1 reference

12 December 2020

Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial

1 reference

12 December 2020

A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis

1 reference

12 December 2020

Effect of somatostatin analog octreotide on human sphincter of Oddi

1 reference

12 December 2020

The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy

1 reference

12 December 2020

Measuring inconsistency in meta-analyses

1 reference

12 December 2020

Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.

1 reference

12 December 2020

Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat

1 reference

12 December 2020

The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography

1 reference

12 December 2020

Meta-analysis: octreotide prevents post-ERCP pancreatitis, but only at sufficient doses

1 reference

12 December 2020

Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis

1 reference

12 December 2020

Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study

1 reference

12 December 2020

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

12 December 2020

Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy

1 reference

12 December 2020

Prevention of post-ERCP pancreatitis: a comprehensive review

1 reference

12 December 2020

Effects of somatostatin on the exocrine pancreas and the release of duodenal hormones

1 reference

12 December 2020

Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study

1 reference

12 December 2020

Can somatostatin prevent injection pancreatitis after ERCP?

1 reference

12 December 2020

Inhibition of cholecystokinin-pancreozymin release by somatostatin

1 reference

12 December 2020

Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial

1 reference

12 December 2020

Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography

1 reference

12 December 2020

Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man

1 reference

12 December 2020

Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis

1 reference

12 December 2020

Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial

1 reference

12 December 2020

Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial

1 reference

12 December 2020

10.1007/S00535-010-0234-4

Identifiers

DOI

1 reference

release_ldtbr6xtgrd5lhzr47ddhbt6i4

14 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ldtbr6xtgrd5lhzr47ddhbt6i4

24 November 2022

mapped directly with Wikidata item

1 reference